Dirty Money: Drug Short

Edit Answers
12345678910111213141516
Across
  1. 5. Environmental, Social, and Governance criteria used to measure the sustainability and ethical impact of an investment.
  2. 7. A deceptive business practice used to inflate sales figures by sending more goods through a distribution channel than it can sell.
  3. 9. An economic situation where the demand for a product does not change significantly even when the price increases.
  4. 11. A market phenomenon where a rapid rise in a stock's price forces short sellers to buy back shares to limit losses, further driving up the price.
  5. 12. The system of rules, practices, and processes by which a firm is directed and controlled, including the oversight provided by the board.
  6. 13. The ability of reported earnings to predict future earnings; high quality is characterized by transparency and sustainability.
  7. 15. A leverage ratio that compares a company's total liabilities to its shareholder equity, indicating the extent of debt financing.
  8. 16. An accounting principle that determines the specific conditions under which revenue is recognized as earned.
Down
  1. 1. The degree to which reported earnings match actual cash flows; low quality often indicates aggressive revenue recognition.
  2. 2. The growth a company achieves by increasing output and enhancing sales internally through its own resources.
  3. 3. An investment strategy where an investor profits from a decline in a stock's price by selling borrowed shares and buying them back later.
  4. 4. When the market is willing to pay more for every dollar of a company's earnings, often driven by high growth expectations.
  5. 6. A financial ratio used to determine how easily a company can pay interest on its outstanding debt.
  6. 8. The use of borrowed money (debt) to finance the purchase of assets, with the expectation that the income will exceed the cost of borrowing.
  7. 10. Revenue growth achieved through mergers and acquisitions rather than internal operations or innovation.
  8. 14. An intangible asset recorded on the balance sheet when one company acquires another for a price higher than its net identifiable assets.